The ‘Better Call Saul' actor was diagnosed with the fatal neurodegenerative disease in 2025, he revealed in a May 16 interview with fiancée Erica Tazel ...
Russell Andrews, an actor and director best known for his roles in “Better Call Saul, " “Grey’s Anatomy” and “NCIS: New ...
ALS is often called the "bankruptcy disease" due to the high cost of treatments and care. But the emotional costs can take a ...
Patients with ALS, or Lou Gehrig's disease, live an average of only three years after symptoms begin, though some can survive ...
Alpha1-antitrypsin deficiency, an inherited disorder affecting 100,000 people in the U.S., causes a progressive and incurable ...
The technology may help predict the way the unpredictable disease progresses in individual patients, Temple researchers say ...
Most people who develop ALS are between 40 and 70; the average age at diagnosis is 55. Now, Goldstein wants to spread ...
The late actor urges lawmakers to reauthorize legislation to help others with ALS in PEOPLE's exclusive clip of the ...
The social media star, now 37, documents her life with the neurodegenerative disease for over 660,000 followers across ...
An experimental RNA-based therapy shows promise for ALS by preventing TDP-43 protein clumping. The therapy halted motor neuron loss in mouse models. Researchers hope to one day move the treatment to ...
About 5,000 people are diagnosed in the U.S. each year. Most ALS patients are given a life expectancy of two to five years ...
COYA 302, an injection therapy in development for the treatment of ALS, has been awarded fast track status by the U.S. Food and Drug Administration. The therapy aims to slow ALS progression by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results